AVDL

Avadel Pharmaceuticals
AVDL

Overview Fund Activity

81 hedge funds and large institutions have $230M invested in Avadel Pharmaceuticals in 2022 Q1 according to their latest regulatory filings, with 16 funds opening new positions, 20 increasing their positions, 23 reducing their positions, and 17 closing their positions.

Holders
81
Holders Change
-2
Holders Change %
-2.41%
% of All Funds
1.28%
Holding in Top 10
1
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-50%
% of All Funds
0.02%
New
16
Increased
20
Reduced
23
Closed
17
Calls
$5.48M
Puts
$2.56M
Net Calls
+$2.92M
Net Calls Change
-$82K

Top Buyers

1
IBT
1
International Biotechnology Trust
United Kingdom
$7.65M
2
FLSM
2
Frazier Life Sciences Management
California
$6.5M
3
ACP
3
Acuta Capital Partners
California
$3.96M
4
Janus Henderson Group
4
Janus Henderson Group
United Kingdom
$9.63M
5
GJL
5
Gendell Jeffrey L
$19.4M

Top Sellers

1
FM
1
Frazier Management
Washington
$0
2
ACM
2
Altium Capital Management
New York
$0
3
CM
3
Caption Management
Oklahoma
$0
4
Qube Research & Technologies (QRT)
4
Qube Research & Technologies (QRT)
United Kingdom
$0
5
WP
5
Woodline Partners
California
$14.5M
Name Market Value Shares Shares
Change 		Shares
Change %
RI
1
RTW Investments
New York
$39.2M 5,741,939 – –
CAC
2
Cowen and Company
New York
$25.5M 3,732,778 – –
BIP
3
Brandes Investment Partners
California
$20.4M 2,988,675 +389,041 +15%
VC
4
Vivo Capital
California
$20.1M 2,937,093 – –
GJL
5
Gendell Jeffrey L
$19.4M 2,837,431 +391,132 +16%
WE
6
Wealth Effects
Massachusetts
$16.2M 2,377,290 +72,273 +3%
WP
7
Woodline Partners
California
$14.5M 2,116,029 -146,973 -6%
ACA
8
Avoro Capital Advisors
New York
$11.4M 1,670,000 – –
Janus Henderson Group
9
Janus Henderson Group
United Kingdom
$9.63M 1,410,387 +407,069 +41%
IBT
10
International Biotechnology Trust
United Kingdom
$7.65M 50,000 +50,000 New
FLSM
11
Frazier Life Sciences Management
California
$6.5M 951,814 +951,814 New
Renaissance Technologies
12
Renaissance Technologies
New York
$5.15M 754,306 -91,500 -11%
SB
13
Samsara BioCapital
California
$4.5M 659,409 – –
ACP
14
Acuta Capital Partners
California
$3.96M 580,000 +580,000 New
MB
15
MPM BioImpact
Massachusetts
$2.82M 412,363 +37,037 +10%
Deutsche Bank
16
Deutsche Bank
Germany
$2.35M 343,407 – –
Morgan Stanley
17
Morgan Stanley
New York
$2.34M 343,009 -114,255 -25%
Susquehanna International Group
18
Susquehanna International Group
Pennsylvania
$1.78M 260,471 +41,813 +19%
Bank of America
19
Bank of America
North Carolina
$1.62M 237,331 +170,136 +253%
DMKJ
20
David M. Knott Jr
$1.42M 207,663 -50,535 -20%
State Street
21
State Street
Massachusetts
$1.41M 205,794 +16,278 +9%
LCM
22
Laurion Capital Management
New York
$1.24M 182,000 +182,000 New
Lazard Asset Management
23
Lazard Asset Management
New York
$998K 146,142 -11,495 -7%
EWM
24
Edge Wealth Management
New York
$990K 145,000 – –
Ameriprise
25
Ameriprise
Minnesota
$880K 128,849 -13,402 -9%
1
2 3 4 5